A Study on Pazhathennai in the mangement of Aseerana pitham (GERD)

An open Non-Randomized Single Arm,Single Centric Clinical Trial to evaluate the effectiveness ofPazhathennai as internal medicine in the mangement of Aseerana Pitham (Gastroesophageal Reflux Disease) among Out Patients attending Ayothidoss Pandithar Hospital,National Institute of Siddha - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/08/056729

Enrollment

Registered

2023-08-22

Start date

Unknown

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis

Interventions

Intervention1: PAZHATHENNAI: 15ml twice a day with warm water for 15days Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Patient who are having symptoms of Aseerana pitham-GERD Regurgitation Heartburn Increased salivation Patient must have atleast any 2 of the following symptoms Bloating Pain in epigastric pain Early satiety Flatulance Discomfort in the chest Patient with endoscopic evidence suggestive of GERD Patient who are willing to sign informed consent form

Exclusion criteria

Exclusion criteria: Peptic ulcer Pancreatitis Appendicitis Pregnancy and lactation

Design outcomes

Primary

Measure	Time frame
Changes in Gastroesophageal reflux disease symptom assessment scale GSAS Scale will be assed before & after treatmentTimepoint: 18 months	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr G Sankareswari

National institute of siddha

drlakshmiramaswamy@gmail.com9444466880

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026